Agnes Rafalko got her PhD in proteomics and nanomedicine at Northeastern. She now works as the Chief Scientific Officer of Glycomine, a startup she herself founded that works on drugs for orphan diseases.

A Northeastern research team have developed new technology that optimizes DNA sequencing using nanophysics and electric currents. In a paper published in Nature Nanotechnology, Northeastern Professor of Biological Physics Meni Wanunu, in partnership with Pacific Biosciences, a biotechnology company with a focus on DNA sequencing, developed a method for loading DNA into sequencing wells with orders of magnitude higher efficiencies.

Professors Srinivas Sridhar and Thomas Webster launched the Nanomedicine Academy of Minority Serving Institutions to bring a diverse workforce into this emerging field and cutting-edge medical advances into the world.

With support from the National Institutes of Health's National Cancer Institute, Northeastern University will partner with the Dana-Farber/Harvard Cancer Center to provide co-op experiences to undergraduate students, who will receive training to study and conduct cancer nanomedicine research.

Each year, nearly $18 bil­lion is spent on nanomed­i­cine research.

From tar­geted drug delivery mech­a­nisms to super­sen­si­tive imaging tech­niques, nan­otech­nology holds many promises for med­i­cine.